CD19 differentially regulates BCR signalling through the recruitment of PI3K

Autoimmunity

Volumn 47, Issue 7, 2014, Pages 430-437

  Xu, Yuekang ^a,b   Fairfax, Kirsten ^a,c   Light, Amanda ^a   Huntington, Nicholas D ^a   Tarlinton, David M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ANHUI NORMAL UNIVERSITY   (China)

^c MONASH UNIVERSITY   (Australia)

Author keywords

B cell activation; Co receptor; Signal transduction

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CALCIUM; CD19 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LYN; LYN PROTEIN-TYROSINE KINASE; PROTEIN TYROSINE KINASE; PROTEIN-TYROSINE KINASE P55(BLK);

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; LIPID RAFT; MOUSE; NONHUMAN; PROTEIN CROSS LINKING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEADY STATE; SUCROSE GRADIENT; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTES; ENZYME ACTIVATION; LYMPHOCYTE ACTIVATION; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84912053957     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.921810     Document Type: Article

References (32)

1. Tedder, T. F., and C. M. Isaacs. 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J. Immunol. 143: 712-717
2. Tuveson, D. A., R. H. Carter, S. P. Soltoff, and D. T. Fearon. 1993. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science (New York, N.Y.) 260: 986-989
3. O'Rourke, L. M., R. Tooze, M. Turner, et al. 1998. CD19 as a membrane-Anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity. 8: 635-645
4. Weng, W. K., L. Jarvis, and T. W. LeBien. 1994. Signaling through CD19 activates Vav/mitogen-Activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269: 32514-32521
5. Tooze, R. M., G. M. Doody, and D. T. Fearon. 1997. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity. 7: 59-67
6. Li, X., and R. H. Carter. 1998. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade. J. Immunol. 161: 5901-5908
7. Fujimoto, M., J. C. Poe, P. J. Jansen, et al. 1999. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162: 7088-7094
8. Fujimoto, M., Y. Fujimoto, J. C. Poe, et al. 2000. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity. 13: 47-57
9. Pezzutto, A., B. Dorken, P. S. Rabinovitch, et al. 1987. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J. Immunol. 138: 2793-2799
10. Rigley, K. P., and R. E. Callard. 1991. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4. Eur. J. Immunol. 21: 535-540
11. Callard, R. E., K. P. Rigley, S. H. Smith, et al. 1992. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used. J. Immunol. 148: 2983-7
12. Fujimoto, M., J. C. Poe, M. Hasegawa, and T. F. Tedder. 2001. CD19 amplification of B lymphocyte Ca2+responses: a role for Lyn sequestration in extinguishing negative regulation. J. Biol. Chem. 276: 44820-44827
13. Zhou, L. J., H. M. Smith, T. J. Waldschmidt, et al. 1994. Tissuespecific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol. Cell. Biol. 14: 3884-3894
14. Xu, Y., S. J. Beavitt, K. W. Harder, et al. 2002. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent. J. Immunol. 169: 6910-6918
15. Jacob, A., D. Cooney, M. Pradhan, and K. M. Coggeshall. 2002. Convergence of signaling pathways on the activation of ERK in B cells. J. Biol. Chem. 277: 23420-23426
16. Otero, D. C., S. A. Omori, and R. C. Rickert. 2001. Cd19-dependent activation of Akt kinase in B-lymphocytes. J. Biol. Chem. 276: 1474-1478
17. Cherukuri, A., P. C. Cheng, H. W. Sohn, and S. K. Pierce. 2001. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity. 14: 169-179
18. Takahashi, K., Y. Kozono, T. J. Waldschmidt, et al. 1997. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J. Immunol. 159: 1557-1569
19. Prodeus, A. P., S. Goerg, L. M. Shen, et al. 1998. A critical role for complement in maintenance of self-tolerance. Immunity. 9: 721-731
20. Boackle, S. A., V. M. Holers, X. Chen, et al. 2001. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity. 15: 775-785
21. Tedder, T. F., M. Inaoki, and S. Sato. 1997. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 6: 107-118
22. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of Tcell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376: 352-355
23. Fujimoto, M., J. C. Poe, A. B. Satterthwaite, et al. 2002. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction. J. Immunol. 168: 5465-5476
24. Aiba, Y., M. Kameyama, T. Yamazaki, et al. 2008. Regulation of Bcell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood. 111: 1497-1503
25. Sato, S., D. A. Steeber, P. J. Jansen, and T. F. Tedder. 1997. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J. Immunol. 158: 4662-4669
26. Harwood, N. E., and F. D. Batista. 2008. New insights into the early molecular events underlying B cell activation. Immunity. 28: 609-619
27. Depoil, D., S. Fleire, B. L. Treanor, et al. 2008. CD19 is essential for B cell activation by promoting B cell receptor-Antigen microcluster formation in response to membrane-bound ligand. Nat. Immunol. 9: 63-72
28. Harwood, N. E., and F. D. Batista. 2011. The cytoskeleton coordinates the early events of B-cell activation. Cold Spring Harb. Perspect. Biol. 3: 1-15
29. Okada, T., A. Maeda, A. Iwamatsu, et al. 2000. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity. 13: 817-827
30. Baracho, G. V., A. V. Miletic, S. A. Omori, et al. 2011. Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation. Curr. Opin. Immunol. 23: 178-183
31. Delgado, P., B. Cubelos, E. Calleja, et al. 2009. Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat. Immunol. 10: 880-888
32. De Fougerolles, A. R., F. Batista, E. Johnsson, and D. T. Fearon. 2001. IgM and stromal cell-Associated heparan sulfate/heparin as complement-independent ligands for CD19. Eur. J. Immunol. 31: 2189-2199